In the News
COVID-19: Frequently Asked Questions (FAQs) for our patients on Immunomodulators.
Welcome to the Dermatology Residencey Class of 2024!
- Taryn DeGrazia
- Brent Folsom
- Thomas Huffaker
- Nirali Patel
- Robin Rolader
- Neha Shukla
Upcoming Events
Dermatology Virtual Grand Rounds**
Thursday, April 2, 2020
8:30-9:30 am
"Allocation of Healthcare Resources
During COVID-19: Distribution
Schemes and Dermatology"
Benjamin K. Stoff, MD, MA
Associate Professor
Department of Dermatology
Emory University
January 16, 2020
Whitehead Auditorium
8:00 am
Fall 2020
Welcome from the Chair
The Department of Dermatology at the Emory University School of Medicine plays important roles locally, regionally, nationally, and internationally. Our primary focus is on skin diseases and the patients affected by them. We look at the problems associated with skin disease from a variety of perspectives both local and global. While we care for individual patients and train learners one at a time, we also view discovery and training from a big picture viewpoint, examining molecular pathways driving skin disorders, skin diseases at population health levels, or perspectives on how to train a healthcare workforce to deal with skin diseases in populations of the future, here and abroad. More...
Recent Publications
Propranolol Exhibits Activity Against Hemangiomas Independent of Beta Blockade
Maiko Sasaki, Paula E. North, Justin Elsey, Jeffrey Bubley, Shikha Rao, Yoonhee Jung, Shengnan Wu, Ming-Hui Zou, Brian P. Pollack, Jayanth Kumar, Hartej Singh, and Jack L. Arbiser
Crushed It: Elucidation of Systemic Vasculitis Caused by Injected Hydromorphone Tablets via Skin Biopsy.
Robin Rolader, Brian Bishop, Zachary W. Eyre, and Justin T. Cheeley
Triple Therapy with Intralesional 5-Fluorouracil, Chemowraps, and Acitretin: A Well-Tolerated Option for Treatment of Widespread Cutaneous Squamous Cell Carcinomas on the Legs
Iviensan F. Manalo, Michael C. Lowe, Kelly C. Nelson, and Suephy C. Chen
E-Cigarette Dermatitis
Timothy E. Holland and Salma de la Feld
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression
Sanjay Chandrasekaran, Maiko Sasaki, Christopher D. Scharer, Haydn T. Kissick, Dillon G. Patterson, Kelly R. Magliocca, John T. Seykora, Bishu Sapkota, David A. Gutman, Lee A. Cooper, Gregory B. Lesinski, Edmund K. Waller, Susan N. Thomas, Sergei V. Kotenko, Jeremy M. Boss, Carlos S. Moreno, Robert A. Swerlick and Brian P. Pollack
